SEC Form 4 · accession 0000911916-16-000634
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A. Nolan Jr.
Officer — Group President
Period of report
Aug 1, 2016
Accepted (ET)
Aug 3, 2016 · 3:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2016 | M | 14,292 | $73.15 | A | 29,091 | D | |
| Common StockF2 | Aug 1, 2016 | S | 14,292 | $130.7279 | D | 14,799 | D | |
| Common Stock | Aug 1, 2016 | M | 4,138 | $94.34 | A | 18,937 | D | |
| Common StockF3 | Aug 1, 2016 | S | 4,138 | $130.7731 | D | 14,799 | D | |
| Common StockF4 | Aug 1, 2016 | S | 6,825 | $130.8468 | D | 7,974 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $73.15 | Aug 1, 2016 | M | 14,292 | D | — | Mar 18, 2023 | Common Stock | 14,292 | 4,763 | D |
| Employee Stock Option (right to buy)F6 | $94.34 | Aug 1, 2016 | M | 4,138 | D | — | Mar 17, 2024 | Common Stock | 4,138 | 4,137 | D |
Explanation of responses
- F1Includes 59 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between May 2, 2016 and June 30, 2016, 37 shares purchased between April 29, 2016 and July 29, 2016 under the dividend reinvestment plan for the Company's common stock, and 20 shares acquired between February 29, 2016 and June 30, 2016 through dividend reinvestment in Mr. Nolan's IRA.
- F2Represents the sale of 14,292 shares in multiple transactions, ranging in price from $130.58 to $130.94 per share, resulting in a weighted average sale price of $130.7279. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F3Represents the sale of 4,138 shares in multiple transactions, ranging in price from $130.68 to $130.90 per share, resulting in a weighted average sale price of $130.7731. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F4Represents the sale of 6,825 shares in multiple transactions, ranging in price from $130.775 to $130.895 per share, resulting in a weighted average sale price of $130.8468. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F54,764 of the options vested on each of March 18, 2014, 2015 and 2016; the remaining 4,763 of the options are scheduled to vest on March 18, 2017.
- F62,069 of the options vested on each of March 17, 2015 and 2016; 2,069 of the options are scheduled to vest on March 17, 2017; and the remaining 2,068 of the options are scheduled to vest on March 17, 2018.